Last reviewed · How we verify
NCT03215420: MRI Meniere
Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease
NA trial testing MRI 3T in Endolymphatic Hydrops in 41 participants. Completed in 3 October 2018.
3 July 2018
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire Dijon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 41 |
| Start date | 8 September 2016 |
| Primary completion | 3 July 2018 |
| Estimated completion | 3 October 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- MRI 3T
Conditions studied
- Endolymphatic Hydrops — all drugs for Endolymphatic Hydrops →
Sponsor
Centre Hospitalier Universitaire Dijon
Who can join
Adults 18 to 75, any sex, with Endolymphatic Hydrops. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to compare 3 methods for the diagnosis of endolymphatic hydrops (EH) in patients with Meniere's disease: MRI 3 Tesla (to visualise EH directly), and functional explorations, namely electrocochleography and dephasing of acoustic distortion products (which are modified by the EH). The research hypothesis is that the examinations will show agreement in the diagnosis of EH, and that the results obtained (quantitative values) will vary in the same direction over time and during flares of MD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03215420
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MRI 3T
Trials testing the same drug.
- NCT06516016 — Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages · not yet recruiting
- NCT03356366 — MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis · NA · active not recruiting
- NCT02576821 — Hippocampal Sclerosis and Amnesia Not Due to Alzheimer's Disease · NA · completed
Other recruiting trials for Endolymphatic Hydrops
Currently open trials in the same condition.
- NCT06910865 — Study of the Radio-clinical Correlation of Endolymphatic Hydrops · recruiting
Other Centre Hospitalier Universitaire Dijon trials
Trials by the same sponsor.
- NCT06608004 — Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT06776848 — A Pilot, Multicentre, Controlled, Open-label Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With · Phase 1, PHASE2 · recruiting
- NCT06347302 — Study of Vitreoretinal Molecular Changes During Rhegmatogenous Retinal Detachment · NA · completed
- NCT06252415 — Evaluation of Rapid First-line Genome Sequencing for Prenatal Diagnosis of Congenital Malformations in Comparison With C · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03215420 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire Dijon
- Last refreshed: 22 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03215420.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing